Drug Trial Radar · NCT05242484
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
577
Actual
Start
Sep 19, 2022
Primary completion
May 15, 2025
Study completion Mar 27, 2029
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- Feb 16, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy and safety of JNJ-78934804 as compared to guselkumab and golimumab in participants with moderately to severely active ulcerative colitis who have had an inadequate initial response, loss of response, or intolerance to one or more approved advanced therapy.
Conditions
- Colitis, Ulcerative
Interventions
GuselkumabBiological
Guselkumab will be administered as subcutaneous injection.
GolimumabBiological
Golimumab will be administered as subcutaneous injection.
JNJ-78934804Biological
JNJ-78934804 will be administered subcutaneously as per defined regimen.
PlaceboDrug
Placebo will be administered as subcutaneous injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants with Clinical Remission at Week 48Time frame: Week 48
Locations
403 sites in 37 countries. Site status is shown where the registry gives one.
Valley Gastroenterology Medical Group
Arcadia, California
Southern California Research Center
Coronado, California
Om Research LLC
Lancaster, California
Cedars Sinai Medical Center
Los Angeles, California
University of California San Francisco
San Francisco, California
University of Colorado
Aurora, Colorado
Peak Gastroenterology Associates
Colorado Springs, Colorado
Medical Research Center of Connecticut
Hamden, Connecticut
Yale University
New Haven, Connecticut
MedStar Georgetown University Hospital
Washington D.C., District of Columbia
Pioneer Research Solutions Inc.
Coconut Creek, Florida
Digestive and Liver Disease Institute
Kissimmee, Florida
Osceola Regional Hospital
Kissimmee, Florida
Florida Research Center Inc.
Lakewood Rch, Florida
University of Miami
Miami, Florida
Gastroenterology Group Of Naples
Naples, Florida
Omega Research Consultants
Orlando, Florida
Synergy Clinical Research
St. Petersburg, Florida
GCP Clinical Research
Tampa, Florida
Atlanta Gastroenterology Associates
Atlanta, Georgia
Gastroenterolgy Associates of Central GA
Macon, Georgia
Atlanta Gastroenterology Associates 1
Marietta, Georgia
Gastrointestinal Specialists of Georgia
Marietta, Georgia
Gastroenterology Consultants
Roswell, Georgia
Grand Teton Gastroenterology
Idaho Falls, Idaho
IU Health University Hospital
Indianapolis, Indiana
Gastroenterology of Southern Indiana
New Albany, Indiana
Tri-State Gastroenterology Assoc
Crestview Hills, Kentucky
University of Kentucky Chandler Medical Center
Lexington, Kentucky
Jewish Hospital
Louisville, Kentucky
Chevy Chase Clinical Research
Chevy Chase, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Brigham And Women's Hospital
Chestnut Hill, Massachusetts
Huron Gastroenterology Associates Center for Digestive Care
Ypsilanti, Michigan
Washington University
St Louis, Missouri
Las Vegas Medical Research
Las Vegas, Nevada
Care Access Las Vegas
Las Vegas, Nevada
Dartmouth Hitchcock
Lebanon, New Hampshire
Weill Cornell Medical College
New York, New York
Lenox Hill Hospital
New York, New York
Showing 40 of 403 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.